Specify a stock or a cryptocurrency in the search bar to get a summary
Polarean Imaging Plc
POLXPolarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom. Address: 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Analytics
WallStreet Target Price
33.22 GBXP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures POLX
Dividend Analytics POLX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History POLX
Stock Valuation POLX
Financials POLX
Results | 2019 | Dynamics |